Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menthacarin in functional gastrointestinal disorders
2022-501800-92-00Phase 4Completed
- Sponsor
- Schwabe Group
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of peppermint oil + caraway oil in functional gastrointestinal disorder (FGID), sponsored by Schwabe Group. Primary endpoints: Patient symptom rating on numeric rating scales, Sum of abdominal symptom ratings and 12 more. Started Mar 2023; status: completed.
02
Drugs
peppermint oil + caraway oil
03
Conditions
functional gastrointestinal disorder (FGID)
Beyond the preview
Go deeper on 2022-501800-92-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501800-92-00.